Host and disease factors are associated with cognitive function in European HIV‐infected adults prior to initiation of antiretroviral therapy |
| |
Authors: | A Winston,W St hr,A Antinori,A Arenas‐Pinto,JM Llibre,H Amieva,A Cabi ,I Williams,G Di Perri,MJ Tellez,J Rockstroh,A Babiker,A Pozniak,F Raffi,L Richert |
| |
Affiliation: | 1. Department of Medicine, Imperial College London, London, UK;2. MRC Clinical Trials Unit at University College London, London, UK;3. Clinical Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy;4. HIV Unit and Lluita contra la SIDA Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain;5. Universitat Autonoma de Barcelona, Barcelona, Spain;6. Centre Inserm U897‐Epidemiologie‐Biostatistique, University of Bordeaux, ISPED, Bordeaux, France;7. Department of Infectious and Tropical Diseases and INSERM CIE802, University Hospital of Fort‐de‐France, Fort‐de‐France, Martinique, France;8. Centre for Sexual Health and HIV Research, Mortimer Market Centre, University College London, London, UK;9. Laboratory of Clinical Pharmacology and Pharmacogenetics (2), Unit of Infectious Diseases, University of Turin, Turin, Italy;10. Department of Medical Sciences, Amedeo di Savoia Hospital, Turin, Italy;11. Infectious Diseases Unit, Internal Medicine, Hospital Clinico Universitario, Madrid, Spain;12. Department of General Internal Medicine I, University Hospital of Bonn, Bonn, Germany;13. Chelsea and Westminster NHS Foundation Trust, London, UK;14. CMIT, Paris, France;15. CHU de Bordeaux, Pole de sante publique, and CIC1401‐EC (Clinical Epidemiology), Bordeaux, France |
| |
Abstract: |
|
| |
Keywords: | antiretroviral naï ve cognitive
HIV
neuropsychological tests |
|
|